Table 3.
Multivariate logistic regression analyses: Predictors of mortality (n=317) and rehospitalization in the stage I cohort (n=286)
| Variables on Admission | Unadjusted OR | Adjusted ORa | 95% CI | P Value |
|---|---|---|---|---|
| Mortality from admission to 1-yr follow-up | ||||
| Age (per 10-yr increase) | 1.83 | 1.71 | 1.25 to 2.35 | 0.004 |
| Treatment with diuretics (yes versus no) | 2.53 | 2.45 | 1.11 to 5.41 | 0.03 |
| NT-proBNP ≥ median (yes versus no) | 2.92 | 2.59 | 1.22 to 5.52 | 0.02 |
| uAGT≥55 μg/g Cr (yes versus no) | 5.19 | 4.47 | 2.10 to 9.54 | 0.001 |
| Rehospitalization from discharge to 1-yr follow-up | ||||
| Diabetes (yes versus no) | 2.20 | 1.94 | 1.00 to 3.80 | 0.05 |
| Preexisting CKD (yes versus no) | 2.86 | 2.41 | 1.04 to 5.60 | 0.02 |
| uAGT≥55 μg/g Cr (yes versus no) | 3.98 | 3.61 | 1.63 to 5.74 | 0.00 |
OR, odds ratio; Cr, creatinine.
a
Adjusted for age, hypertension, diabetes, preexisting CKD, serum albumin, NT-proBNP, hemoglobin, UACR, treatment with an angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, treatment with diuretics, and centers. Hosmer–Lemeshow goodness-of-fit test: for mortality, chi-squared value=6.035 (P=0.64); and for rehospitalization, chi-squared value=1.837 (P=0.87).